Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

New ARP President Janet Poole, PhD, OTR/L, FAOTA, Plans to Build Membership & Address Workforce Shortages

Carol Patton  |  November 6, 2019

This week, long-time ARP member Janet Poole, PhD, OTR/L, FAOTA, becomes the organization’s 51st president. Dr. Poole is a professor and division chief of the occupational therapy graduate program in the School of Medicine at the University of New Mexico, Albuquerque. Her research has focused on scleroderma and other rheumatic diseases, specifically how they impact the ability to perform daily life tasks.

Janet Poole

Dr. Janet Poole

Over the years, she has conducted numerous studies examining rehabilitation interventions for patients with scleroderma, co-developed a self-management program called Taking Charge of Systemic Sclerosis (TOSS) and authored several textbook chapters on rehabilitation for people with the disease.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Poole has been very active in the ARP since joining more than 30 years ago. She has served on the Executive, Practice, Membership, Research and Annual Meeting Planning committees. She was a grant reviewer for the Rheumatology Research Foundation Study Section and ARP liaison to the ACR’s Education and Research committees. The ARP has also recognized her efforts and accomplishments with several awards: Master Clinician (2012), Master Educator (2014) and Distinguished Lecturer (2018).

The Rheumatologist spoke with Dr. Poole about the ARP’s priorities and the challenges and opportunities that lay ahead.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Rheumatologist (TR): In recent years, the ARP has focused on three key areas: securing more funding for arthritis research, advocating for legislation on regulatory relief and prior authorization reform and attracting more healthcare providers to the field of rheumatology. As ARP president, will you pursue different goals or priorities?

Dr. Poole: I plan to address the workforce shortage by encouraging more health professionals from different disciplines to enter rheumatology. There’s an approaching tsunami of people who are turning 65 years of age. Many of these older adults will develop rheumatic diseases, such as osteoarthritis, osteoporosis and other musculoskeletal conditions. We willl be in an ideal position to continue building our ARP interprofessional membership team by developing educational and other resources and promoting the rheumatology field to nurses, pharmacists, occupational therapists, physical therapists, social workers, nurse practitioners, physician assistants, health educators, practice managers, psychologists and others. They’ll all be needed to manage the health of this influx of older people. As part of this communication, recruiting and education campaign, the ARP has already created flyers that describe benefits of membership to healthcare professionals in different disciplines. Hopefully, within the next several years, our efforts will help boost ARP membership and most importantly, improve the lives of people with rheumatic and musculoskeletal diseases.

Page: 1 2 3 | Single Page
Share: 

Filed under:American College of Rheumatology Tagged with:ARP presidentAssociation of Rheumatology Professionals (ARP)Janet PooleOccupational Therapy

Related Articles

    The 2022 ARP President’s & Merit Awards

    November 6, 2022

    During ACR Convergence 2022 in early November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the recipients of the ARP President’s and Merit Awards. ARP PRESIDENT’S AWARDS The ARP president can choose to honor ACR/ARP…

    The 2021 ARP President’s Awards & Merit Awards

    November 14, 2021

    During ACR Convergence 2021 in early November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the winners of the ARP President’s and Merit Awards. ARP PRESIDENT’S AWARDS The ARP president can choose to honor ACR/ARP…

    Dr. Breland

    New Membership & Nominations Chair Dr. Hazel Breland Outlines Goals for ARP Membership Growth

    January 24, 2020

    Having completed her term as ARP president, Hazel L. Breland, PhD, OTR/L, FAOTA, CLA, has stepped into a new role as chair of the ARP’s Membership and Nominations Committee (https://www.rheumatology.org/Rheumatology-Professionals). Dr. Breland is associate professor of occupational therapy at the Medical University of South Carolina (MUSC), Charleston, where she teaches graduate students and serves as…

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences